My question - does NEU have a best endeavours agreement for Fragile X with Acadia for North America - was not answered.
JP stated that it was Acadia's intention to wait for approval before progressing Fragile X.
Now that Daybue is approved, I'm wondering (hottod) what options this gives Acadia in getting approval for Fragile X. Do they, for example have to do the traditional phase 3 trial or can they go down an alternative route.
Ann: Investor Presentation, 14 March 2023, page-7
-
- There are more pages in this discussion • 139 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.52 |
Change
0.660(3.32%) |
Mkt cap ! $2.622B | |||
| Open | High | Low | Value | Volume |
| $20.00 | $20.66 | $19.94 | $6.431M | 315.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1024 | $20.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.53 | 285 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |